Regulation of c-fos expression by the dopamine D1-D2 receptor heteromer

Neuroscience

Volumn 285, Issue , 2015, Pages 194-203

  Perreault, M L ^a,b   Shen, M Y F ^a,b   Fan, T ^a,b   George, S R ^a,b,c  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

C fos; Cortex; Dopamine D1 D2 heteromer; Lateral habenula; Nucleus accumbens

Indexed keywords

6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 3 METHYL 1 (3 METHYLPHENYL) 1H 3 BENZAZEPINE; CALCIUM; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; ISOFLURANE; KETOPROFEN; PROTEIN C FOS; RECEPTOR SUBTYPE; TRANSACTIVATOR PROTEIN; 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; DOPAMINE RECEPTOR BLOCKING AGENT; SK&F 83959;

ADULT; AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ARTICLE; BRAIN MAPPING; BRAIN REGION; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CAUDATE NUCLEUS; CONTROLLED STUDY; CORPUS STRIATUM; GLOBUS PALLIDUS; HABENULA; HIPPOCAMPUS; HYPOTHALAMUS; IMMUNOCHEMISTRY; IMMUNOREACTIVITY; LIMBIC CORTEX; MALE; NONHUMAN; NUCLEUS ACCUMBENS; OLFACTORY NUCLEUS; ORBITAL CORTEX; PEDUNCULOPONTINE TEGMENTAL NUCLEUS; PROTEIN EXPRESSION; PROTEIN INDUCTION; PUTAMEN; PYRIFORM CORTEX; RAT; SUBSTANTIA NIGRA; THALAMUS NUCLEUS; VENTRAL TEGMENTUM; ANALOGS AND DERIVATIVES; ANIMAL; BRAIN; CELL COUNT; DIMERIZATION; DRUG EFFECTS; IMMUNOHISTOCHEMISTRY; METABOLISM; NERVE CELL; SPRAGUE DAWLEY RAT;

2,3,4,5-TETRAHYDRO-7,8-DIHYDROXY-1-PHENYL-1H-3-BENZAZEPINE; ANIMALS; BRAIN; CELL COUNT; DIMERIZATION; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; IMMUNOHISTOCHEMISTRY; MALE; NEURONS; PROTO-ONCOGENE PROTEINS C-FOS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2;

EID: 84916613835     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2014.11.017     Document Type: Article

References (48)

1. Aubert I., Ghorayeb I., Normand E., Bloch B. Phenotypical characterization of the neurons expressing the D1 and D2 dopamine receptors in the monkey striatum. J Comp Neurol 2000, 418:22-32.
2. Bertran-Gonzalez J., Bosch C., Maroteaux M., Matamales M., Herve D., Valjent E., Girault J.A. Opposing patterns of signaling activation in dopamine D1 and D2 receptor-expressing striatal neurons in response to cocaine and haloperidol. J Neurosci 2008, 28:5671-5685.
3. Boyson S.J., McGonigle P., Molinoff P.B. Quantitative autoradiographic localization of the D1 and D2 subtypes of dopamine receptors in rat brain. J Neurosci 1986, 6:3177-3188.
4. Chun L.S., Free R.B., Doyle T.B., Huang X.P., Rankin M.L., Sibley D.R. D1-D2 dopamine receptor synergy promotes calcium signaling via multiple mechanisms. Mol Pharmacol 2013, 84:190-200.
5. Cools A.R., Lubbers L., van Oosten R.V., Andringa G. SKF 83959 is an antagonist of dopamine D1-like receptors in the prefrontal cortex and nucleus accumbens: a key to its antiparkinsonian effect in animals?. Neuropharmacology 2002, 42:237-245.
6. Culver K.E., Rosenfeld J.M., Szechtman H. A switch mechanism between locomotion and mouthing implicated in sensitization to quinpirole in rats. Psychopharmacology (Berl) 2000, 151:202-210.
7. Deng Y.P., Lei W.L., Reiner A. Differential perikaryal localization in rats of D1 and D2 dopamine receptors on striatal projection neuron types identified by retrograde labeling. J Chem Neuroanat 2006, 32:101-116.
8. Deveney A.M., Waddington J.L. Pharmacological characterization of behavioural responses to SK&F 83959 in relation to 'D1-like' dopamine receptors not linked to adenylyl cyclase. Br J Pharmacol 1995, 116:2120-2126.
9. Downes R.P., Waddington J.L. Grooming and vacuous chewing induced by SK&F 83959, an agonist of dopamine 'D1-like' receptors that inhibits dopamine-sensitive adenylyl cyclase. Eur J Pharmacol 1993, 234:135-136.
10. Dubois A., Savasta M., Curet O., Scatton B. Autoradiographic distribution of the D1 agonist [3H]SKF 38393, in the rat brain and spinal cord. Comparison with the distribution of D2 dopamine receptors. Neuroscience 1986, 19:125-137.
11. Gangarossa G., Espallergues J., de Kerchove d'Exaerde A., El Mestikawy S., Gerfen C.R., Hervé D., Girault J.A., Valjent E. Distribution and compartmental organization of GABAergic medium-sized spiny neurons in the mouse nucleus accumbens. Front Neural Circuits 2013, 7:22.
12. Guo L., Zhao J., Jin G., Zhao B., Wang G., Zhang A., Zhen X. SKF83959 is a potent allosteric modulator of sigma-1 receptor. Mol Pharmacol 2013, 83:577-586.
13. Hasbi A., Fan T., Alijaniaram M., Nguyen T., Perreault M.L., O'Dowd B.F., George S.R. Calcium signaling cascade links dopamine D1-D2 receptor heteromer to striatal BDNF production and neuronal growth. Proc Natl Acad Sci USA 2009, 106:21377-21382.
14. Hasbi A., Perreault M.L., Shen M.Y.F., Zhang L., To R., Fan T., Ji X., Nguyen T.F., O'Dowd B.F., George S.R. A peptide targeting an interaction interface disrupts the dopamine D1-D2 receptor heteromer to block signaling and function in vitro and in vivo: effective selective antagonism. FASEB J 2014, 28:4806-4820.
15. Jin L.Q., Goswami S., Cai G., Zhen X., Friedman E. SKF83959 selectively regulates phosphatidylinositol-linked D1 dopamine receptors in rat brain. J Neurochem 2003, 85:378-386.
16. Kozlovsky N., Nadri C., Agam G. Low GSK-3beta in schizophrenia as a consequence of neurodevelopmental insult. Eur Neuropsychopharmacol 2005, 15:1-11.
17. LaHoste G.J., Yu J., Marshall J.F. Striatal Fos expression is indicative of dopamine D1/D2 synergism and receptor supersensitivity. Proc Natl Acad Sci USA 1993, 90:7451-7455.
18. Lee S.M., Kant A., Blake D., Murthy V., Boyd K., Wyrick S.J., Mailman R.B. SKF-83959 is not a highly-biased functionally selective D dopamine receptor ligand with activity at phospholipase C. Neuropharmacology 2014, [Epub ahead of print]. 10.1016/j.neuropharm.2014.05.042.
19. Lee S.P., So C.H., Rashid A.J., Varghese G., Cheng R., Lanca A.J., O'Dowd B.F., George S.R. Dopamine D1 and D2 receptor Co-activation generates a novel phospholipase C-mediated calcium signal. J Biol Chem 2004, 279:35671-35678.
20. Lester J., Fink S., Aronin N., DiFiglia M. Colocalization of D1 and D2 dopamine receptor mRNAs in striatal neurons. Brain Res 1993, 621:106-110.
21. Levant B., Grigoriadis D.E., DeSouza E.B. Characterization of [3H]quinpirole binding to D2-like dopamine receptors in rat brain. J Pharmacol Exp Ther 1992, 262:929-935.
22. Llorens-Maritin M., Jurado J., Hernandez F., Avila J. GSK-3beta, a pivotal kinase in Alzheimer disease. Front Mol Neurosci 2014, 7:46.
23. Mansour A., Meador-Woodruff J.H., Bunzow J.R., Civelli O., Akil H., Watson S.J. Localization of dopamine D2 receptor mRNA and D1 and D2 receptor binding in the rat brain and pituitary: an in situ hybridization-receptor autoradiographic analysis. J Neurosci 1990, 10:2587-2600.
24. Matamales M., Bertran-Gonzalez J., Salomon L., Degos B., Deniau J.M., Valjent E., Hervé D., Girault J.A. Striatal medium-sized spiny neurons: identification by nuclear staining and study of neuronal subpopulations in BAC transgenic mice. PLoS One 2009, 4:e4770.
25. Meador-Woodruff J.H., Mansour A., Healy D.J., Kuehn R., Zhou Q.Y., Bunzow J.R., Akil H., Civelli O., Watson S.J. Comparison of the distributions of D1 and D2 dopamine receptor mRNAs in rat brain. Neuropsychopharmacology 1991, 5:231-242.
26. Ng J., Rashid A.J., So C.H., O'Dowd B.F., George S.R. Activation of calcium/calmodulin-dependent protein kinase IIalpha in the striatum by the heteromeric D1-D2 dopamine receptor complex. Neuroscience 2010, 165:535-541.
27. Noonan M.P., Kolling N., Walton M.E., Rushworth M.F. Re-evaluating the role of the orbitofrontal cortex in reward and reinforcement. Eur J Neurosci 2012, 35:997-1010.
28. O'Dowd B.F., Ji X., Nguyen T., George S.R. Two amino acids in each of D1 and D2 dopamine receptor cytoplasmic regions are involved in D1-D2 heteromer formation. Biochem Biophys Res Commun 2012, 417:23-28.
29. Paul M.L., Graybiel A.M., David J.C., Robertson H.A. D1-like and D2-like dopamine receptors synergistically activate rotation and c-fos expression in the dopamine-depleted striatum in a rat model of Parkinson's disease. J Neurosci 1992, 12:3729-3742.
30. Pei L., Li S., Wang M., Diwan M., Anisman H., Fletcher P.J., Nobrega J.N., Liu F. Uncoupling the dopamine D1-D2 receptor complex exerts antidepressant-like effects. Nat Med 2010, 16:1393-1395.
31. Perez-Cadahia B., Drobic B., Davie J.R. Activation and function of immediate-early genes in the nervous system. Biochem Cell Biol 2011, 89:61-73.
32. Perreault M.L., Fan T., Alijaniaram M., O'Dowd B.F., George S.R. Dopamine D1-D2 receptor heteromer in dual phenotype GABA/Glutamate-coexpressing striatal medium spiny neurons: regulation of BDNF, GAD67 and VGLUT1/2. PLoS One 2012, 7:e33348.
33. Perreault M.L., Hasbi A., Alijaniaram M., Fan T., Varghese G., Fletcher P.J., Seeman P., O'Dowd B.F., George S.R. The dopamine D1-D2 receptor heteromer localizes in dynorphin/enkephalin neurons: increased high affinity state following amphetamine and in schizophrenia. J Biol Chem 2010, 285:36625-36634.
34. Perreault M.L., Hasbi A., O'Dowd B.F., George S.R. The dopamine d1-d2 receptor heteromer in striatal medium spiny neurons: evidence for a third distinct neuronal pathway in basal ganglia. Front Neuroanat 2011, 5:31.
35. Perreault M.L., Jones-Tabah J., O'Dowd B.F., George S.R. A physiological role for the dopamine D5 receptor as a regulator of BDNF and Akt signalling in rodent prefrontal cortex. Int J Neuropsychopharmacol 2013, 25:1-7.
36. Rashid A.J., So C.H., Kong M.M., Furtak T., El-Ghundi M., Cheng R., O'Dowd B.F., George S.R. D1-D2 dopamine receptor heterooligomers with unique pharmacology are coupled to rapid activation of Gq/11 in the striatum. Proc Natl Acad Sci USA 2007, 104:654-659.
37. Robertson H.A., Paul M.L., Moratalla R., Graybiel A.M. Expression of the immediate early gene c-fos in basal ganglia: induction by dopaminergic drugs. Can J Neurol Sci 1991, 18:380-383.
38. Sahu A., Tyeryar K.R., Vongtau H.O., Sibley D.R., Undieh A.S. D5 dopamine receptors are required for dopaminergic activation of phospholipase C. Mol Pharmacol 2009, 75:447-453.
39. Sundquist S.J., Nisenbaum L.K. Fast Fos: rapid protocols for single- and double-labeling c-Fos immunohistochemistry in fresh frozen brain sections. J Neurosci Methods 2005, 141:9-20.
40. Surmeier D.J., Eberwine J., Wilson C.J., Cao Y., Stefani A., Kitai S.T. Dopamine receptor subtypes colocalize in rat striatonigral neurons. Proc Natl Acad Sci USA 1992, 89:10178-10182.
41. Surmeier D.J., Song W.J., Yan Z. Coordinated expression of dopamine receptors in neostriatal medium spiny neurons. J Neurosci 1996, 16:6579-6591.
42. Trugman J.M., James C.L., Wooten G.F. D1/D2 dopamine receptor stimulation by l-dopa. A [14C]-2-deoxyglucose autoradiographic study. Brain 1991, 114:1429-1440.
43. Wirtshafter D., Krebs J.C. Interactive effects of stimulation of D1 and D2 dopamine receptors on Fos expression in the lateral habenula. Brain Res 1997, 750:245-250.
44. Wirtshafter D., Osborn C.V. The atypical dopamine D1 receptor agonist SKF 83959 induces striatal Fos expression in rats. Eur J Pharmacol 2005, 528:88-94.
45. Young K.A., Wilcox R.E. Characterization of D2 receptors and dopamine levels in the thalamus of the rat. Life Sci 1991, 48:1845-1852.
46. Zenko M., Zhu Y., Dremencov E., Ren W.Xu.L., Zhang X. Requirement for the endocannabinoid system in social interaction impairment induced by coactivation of dopamine D1 and D2 receptors in the piriform cortex. J Neurosci Res 2011, 89:1245-1258.
47. Zhang Z.W., Burke M.W., Calakos N., Beaulieu J.M., Vaucher E. Confocal analysis of cholinergic and dopaminergic inputs onto pyramidal cells in the prefrontal cortex of rodents. Front Neuroanat 2010, 4:21.
48. Zuo W., Chen L., Wang L., Ye J.H. Cocaine facilitates glutamatergic transmission and activates lateral habenular neurons. Neuropharmacology 2013, 70:180-189.